Streptococcus agalactiae, also known as GBS, can cause urinary tract infections and in some serious cases, infections of the blood or pneumonia. This is a research study for an investigational vaccine intended to help prevent streptococcus disease.
- Must be a woman age 18 to 40
- Must either not be pregnant OR be pregnant and within 24 to 35 weeks of gestation
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can talk to a Meridian enrollment specialist about this study by calling (712) 639-6200.
Submit your information
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.